Skip to content
WeighLab

REMEVi vs SnagRx

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

REMEVi

Provider comparison

Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.

Semaglutide / month
$199 per 4 weeksMonth-to-month, same at every dose; $159 per 4 weeks on a 24-week plan paid up front, compounded
Tirzepatide / month
$269 per 4 weeksMonth-to-month, same at every dose; $225 per 4 weeks on a 24-week plan paid up front, compounded
Index 82/100 · Grade B−Checked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check REMEVi pricing Read review

SnagRx

Provider comparison

Budget shoppers who want a low flat price and a named compounding pharmacy, and who are comfortable with a strict refund policy.

Semaglutide / month
$99/moMonth-to-month, same price at every dose ($89 on a 3-month plan, $79 on 6 months, $69 on 12 months)
Tirzepatide / month
$149/moMonth-to-month, same price at every dose ($139 on a 3-month plan, $129 on 6 months, $119 on 12 months)
Index 81/100 · Grade B−Checked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check SnagRx pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

REMEVi has the higher Cost-Efficiency Index: 82/100 versus 81/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

REMEVi
49 states + DC
SnagRx
All states except Louisiana (Nebraska: 19 and older)

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

REMEVi

SnagRx

Semaglutide / month
REMEVi: $199 per 4 weeksMonth-to-month, same at every dose; $159 per 4 weeks on a 24-week plan paid up front, compounded
SnagRx: $99/moMonth-to-month, same price at every dose ($89 on a 3-month plan, $79 on 6 months, $69 on 12 months)
Tirzepatide / month
REMEVi: $269 per 4 weeksMonth-to-month, same at every dose; $225 per 4 weeks on a 24-week plan paid up front, compounded
SnagRx: $149/moMonth-to-month, same price at every dose ($139 on a 3-month plan, $129 on 6 months, $119 on 12 months)
Semaglutide / year (modeled)
REMEVi: $2,58713 charges
SnagRx: $1,188
Tirzepatide / year (modeled)
REMEVi: $3,49713 charges
SnagRx: $1,788
State availability
REMEVi: 49 states + DC
SnagRx: All states except Louisiana (Nebraska: 19 and older)
Oral / sublingual option listed
REMEVi: Yes
SnagRx: Not listed
Brand-name access listed
REMEVi: Not confirmed
SnagRx: Not confirmed
Provider facts checked
REMEVi: October 2026
SnagRx: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

REMEVi

Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.

Reasons to consider it

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly rather than used as a teaser: semaglutide falls to $169 every 4 weeks on a 12-week plan and $159 on a 24-week plan
  • A daily oral semaglutide tablet is offered alongside the injection

What to weigh up

  • Billing runs every 4 weeks, so a year of month-to-month care is 13 charges, and the lowest $159 rate needs 24 weeks paid up front
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Compounded drugs are not FDA-approved. Understand the medication options.

Check REMEVi pricing Read the full REMEVi review

SnagRx

Budget shoppers who want a low flat price and a named compounding pharmacy, and who are comfortable with a strict refund policy.

Reasons to consider it

  • Low flat month-to-month prices that don't rise with the dose, with no membership fee
  • Names four specific, checkable compounding pharmacy partners
  • Serves every state except Louisiana

What to weigh up

  • The homepage's $69 and $119 "sale" prices are the 12-month rates, shown against a struck-through $299 and $349; month to month it's $99 and $149
  • All sales are final, and multi-month plans are non-refundable in whole and in part
  • Medical director exists but is not named

Compounded drugs are not FDA-approved. Understand the medication options.

Check SnagRx pricing Read the full SnagRx review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

REMEViSnagRx
Normalized Cost/Month
REMEVi:
74/100
SnagRx:
95/100
Price Transparency
REMEVi:
94/100
SnagRx:
97/100
Nationwide Access
REMEVi:
86/100
SnagRx:
78/100
Formulation Options
REMEVi:
77/100
SnagRx:
66/100
Clinical Oversight
REMEVi:
87/100
SnagRx:
76/100
Contract Flexibility
REMEVi:
69/100
SnagRx:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to REMEViAlternatives to SnagRx
More provider matchups
CoreAge Rx vs REMEViCoreAge Rx vs SnagRx
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.